Presented by The Coalition to Strengthen America’s Healthcare{beacon} Health Care Health Care   The Big Story PhRMA warns ...

President Trump's bombshell executive order aimed at lowering U.S. drug prices is a step toward a worst-case scenario for the ...

It's no secret that brand-name drugs in the U.S. are much more expensive than they are abroad. In the spirit of fairness, the ...

This may mean another bull run for pharma stocks, and PJP would be one of the best ways to gain exposure to it. Investors should proceed with this reminder in mind: Position sizing is often more ...

Earnings Estimate Revisions for Astellas Pharma This company is expected to earn $0.82 per share for the fiscal year ending March 2026, which represents a year-over-year change of -24.8%.

The pharmaceutical industry has been left in a ... “As it stands, pricing controls mean that certain US-made drugs are already not available in the UK.” However, pricing controls alone cannot ...